Atlas Trials

"Galectin-3 as a Marker of Subclinical Inflammation in FMF"

Clinical trial NCT06451471 · COMPLETED

Trial details

NCT number
NCT06451471
Sponsor
Turkish League Against Rheumatism
Status
COMPLETED
Study type
OBSERVATIONAL
Ailesel Akdeniz Ateşi
Start date
2021-05-01
Primary completion
2022-11-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.